Macuject is a clinician-driven digital health company created to end preventable blindness for tens of millions across the globe, starting with age-related macular degeneration (AMD); diabetic retinopathy, cataract and glaucoma will follow. Our innovative clinical decision support software is specifically designed to address both wet and dry forms of AMD, empowering healthcare professionals to make accurate and timely diagnoses, optimise treatment plans, and monitor disease progression more effectively. By harnessing the power of cutting-edge artificial intelligence and integrating seamlessly with existing medical infrastructure, our SaaS solutions enable early intervention and personalized care, dramatically improving patient outcomes and significantly reducing the social and economic burden of these blinding conditions. Macuject’s founder-CEO is Dr. Devinder Chauhan, a prominent Melbourne retinal specialist responsible for 8% of his state's AMD treatments. Leveraging his expertise and network, he has brought together a talented team of professionals with diverse backgrounds in commercial, technical and clinical development. Our collaborative team is dedicated to developing, refining, and promoting our ground-breaking products, ensuring both their clinical relevance and market adoption.

Website: http://www.macuject.com

Employees: 9

HQ: N/A

Location: N/A, N/A, au

Revenue: Not Available

Are you looking for contact information for Macuject? You've come to the right place! ConnectPlex is a leading provider of B2B contact information, and we have all the details you need to get in touch with Macuject's team. Our database contains millions of company records, and we can help you connect with the right people to grow your business. Whether you're looking to partner, collaborate, or sell your products or services, our contact information for Macuject will help you reach your goals. At ConnectPlex, we understand the importance of accurate and up-to-date contact information. That's why we constantly update our database to ensure that our records are current and reliable. Our team of experts works tirelessly to research and verify contact information for companies like Macuject, so you can be confident that you're getting the best possible leads. With our contact information, you'll be able to reach key decision-makers and professionals within Macuject, and start building valuable business relationships. So why wait? Start your search for Macuject's contact information today and let ConnectPlex be your partner in business growth!

Macuject: Revolutionizing the Treatment of Blinding Retinal Disease Macuject is a software platform that is changing the game in the treatment of blinding retinal disease. With a mission to prevent blindness by guiding doctors and patients to individually optimised treatment strategies, Macuject is dedicated to ensuring that patients receive the best visual outcomes possible. Founded in Melbourne, Australia, Macuject's innovative approach to treatment is designed to streamline workflows, provide decision support, and integrate AI-powered image analysis, patient history, and optimal treatment protocols. The company's focus on personalised treatment strategies benefits not only patients, but also doctors and the healthcare system as a whole. By linking decision-making behaviours to optimal outcomes and reduced societal burden, Macuject's approach has the potential to revolutionize the treatment of blinding retinal disease. With a talented team led by CEO-founder Devinder Chauhan and Chief Technology Officer Bradley Beddoes, Macuject is poised to make a significant impact in the medical community.

At Macuject, we believe that everyone should have the right to good vision. Unfortunately, many people lose their sight every year because they don't have access to the right treatment. Macuject is a software platform that aims to change this by helping doctors and patients find the best treatment for eye diseases. Our goal is to prevent blindness by providing personalized treatment plans that work best for each patient. Patients will get the best possible vision, and doctors will have an easier time making decisions with the help of AI technology and up-to-date information. This will also benefit the healthcare system by reducing the financial burden of eye diseases. By working together, we can make sure that everyone has access to the best eye care and can see the world clearly.